View Older Stories

Feb 18, 2026 04:23PM Clear Street Upgrades Korro Bio Inc. (KRRO) to Buy

Jan 29, 2026 06:39AM H.C. Wainwright Upgrades Korro Bio Inc. (KRRO) to Buy

Jan 29, 2026 12:35AM Piper Sandler Upgrades Korro Bio Inc. (KRRO) to Overweight

Jan 29, 2026 12:34AM Chardan Capital Markets Upgrades Korro Bio Inc. (KRRO) to Buy

Jan 28, 2026 07:09AM William Blair Reiterates Market Perform Rating on Korro Bio Inc. (KRRO), 'early stages of its pipeline with clinical data unlikely until 2027'

Jan 28, 2026 07:08AM Raymond James Reiterates Market Perform Rating on Korro Bio Inc. (KRRO)

Jan 28, 2026 06:58AM Oppenheimer Upgrades Korro Bio Inc. (KRRO) to Outperform

Jan 28, 2026 05:27AM Cantor Fitzgerald Upgrades Korro Bio Inc. (KRRO) to Overweight

Jan 28, 2026 01:05AM Jones Trading Reiterates Hold Rating on Korro Bio Inc. (KRRO)

Jan 28, 2026 01:05AM Jones Trading Reiterates Hold Rating on Korro Bio Inc. (KRRO)

Jan 27, 2026 04:12PM Korro Bio Inc. (KRRO) PT Raised to $10 at Clear Street

Nov 13, 2025 05:03PM Korro Bio (KRRO) Misses Q3 EPS by 192c

Nov 13, 2025 07:42AM Piper Sandler Downgrades Korro Bio Inc. (KRRO) to Neutral

Nov 13, 2025 06:38AM H.C. Wainwright Downgrades Korro Bio Inc. (KRRO) to Neutral

Nov 13, 2025 05:59AM William Blair Downgrades Korro Bio Inc. (KRRO) to Market Perform

Nov 13, 2025 05:55AM RBC Capital Downgrades Korro Bio Inc. (KRRO) to Sector Perform

Nov 13, 2025 04:15AM Raymond James Downgrades Korro Bio Inc. (KRRO) to Market Perform

Nov 13, 2025 03:05AM Chardan Capital Markets Downgrades Korro Bio Inc. (KRRO) to Neutral

Nov 13, 2025 02:45AM Cantor Fitzgerald Downgrades Korro Bio Inc. (KRRO) to Neutral

Nov 13, 2025 02:43AM Clear Street Downgrades Korro Bio Inc. (KRRO) to Hold

Nov 12, 2025 04:52PM Korro Bio reports mixed results from KRRO-110 trial, cuts workforce by third

Oct 30, 2025 04:35PM Clear Street Starts Korro Bio Inc. (KRRO) at Buy

Oct 24, 2025 08:29AM Piper Sandler: 'Biotech Has a Heartbeat: 17 Stocks to Own Through YE25'

Sep 17, 2025 07:35AM BMO Capital Reiterates Outperform Rating on Korro Bio Inc. (KRRO)

Aug 13, 2025 06:55AM Korro Bio Inc. (KRRO) PT Lowered to $90 at H.C. Wainwright

Aug 13, 2025 05:29AM Korro Bio Inc. (KRRO) PT Lowered to $147 at Raymond James

Aug 12, 2025 04:22PM Korro Bio (KRRO) Misses Q2 EPS by 274c

Jul 24, 2025 06:40AM H.C. Wainwright Reiterates Buy Rating on Korro Bio Inc. (KRRO)

Jul 22, 2025 06:40AM H.C. Wainwright Reiterates Buy Rating on Korro Bio Inc. (KRRO)

Jul 21, 2025 08:04AM Korro Bio receives European orphan drug designation for KRRO-110

May 8, 2025 06:43AM Korro Bio Inc. (KRRO) PT Lowered to $100 at H.C. Wainwright

May 7, 2025 05:57PM Korro Bio (KRRO) Misses Q1 EPS by 249c

Apr 29, 2025 05:46AM Cantor Fitzgerald Starts Korro Bio Inc. (KRRO) at Overweight

Apr 16, 2025 01:12AM Chardan Capital Markets Starts Korro Bio Inc. (KRRO) at Buy

Apr 1, 2025 07:32AM Korro Bio (KRRO) Appoints Loïc Vincent as Chief Scientific Officer

Mar 20, 2025 06:43AM H.C. Wainwright Reiterates Buy Rating on Korro Bio Inc. (KRRO)

Mar 14, 2025 08:01AM Korro Bio (KRRO): KRRO-110 Receives Orphan Drug Designation from U.S. FDA for Alpha-1 Antitrypsin Deficiency

Feb 11, 2025 05:03PM Korro Bio CFO takes medical leave, interim officers appointed

Dec 21, 2024 10:00AM RBC report: Biotech faces both uncertainty and growth opportunities in 2025

Dec 20, 2024 12:46PM BMO Capital Highlights Favorite Names for 2025 in Biotech

Dec 2, 2024 04:24PM Korro Bio (KRRO) Files $400M Mixed Shelf

Nov 21, 2024 07:30AM Korro Bio (KRRO) Receives Australian HREC Approval and CTN Clearance to Initiate Phase 1/2a Clinical Study (REWRITE) of KRRO-110 for Alpha-1 Antitrypsin Deficiency

Nov 18, 2024 03:25AM Jones Trading Starts Korro Bio Inc. (KRRO) at Buy

Nov 13, 2024 04:44PM Korro Bio (KRRO) Misses Q3 EPS by 226c

Oct 21, 2024 06:45AM Korro Bio Inc. (KRRO) PT Raised to $105 at RBC Capital

Oct 18, 2024 06:40AM Korro Bio Inc. (KRRO) PT Raised to $115 at H.C. Wainwright

Oct 16, 2024 12:44PM BMO Capital Reiterates Outperform Rating on Korro Bio Inc. (KRRO)

Sep 17, 2024 07:26AM BMO Capital Reiterates Outperform Rating on Korro Bio Inc. (KRRO)

Sep 17, 2024 06:54AM H.C. Wainwright Reiterates Buy Rating on Korro Bio Inc. (KRRO)

Sep 17, 2024 05:53AM Piper Sandler Reiterates Overweight Rating on Korro Bio Inc. (KRRO)

View Older Stories